Methyltestosterone (Android)

370  relevant articles (11 outcomes, 26 trials/studies) found for this Drug

Android; Oreton; Virilon; Testred; 17 beta Methyltestosterone; 17 beta-Hydroxy-17-methyl-4-androsten-3-one; 17 beta-Methyltestosterone; 17-Epimethyltestosterone; 17-alpha-Methyltestosterone; 17alpha-Methyl-Testosterone; 17alpha-Methyltestosterone; 17beta-Hydroxy-17-methyl-4-androsten-3-one; 17beta-Methyltestosterone; Android-10; Android-25; Android-5; Global Pharmaceutical Brand of Methyltestosterone; ICN Brand 1 of Methyltestosterone; ICN Brand 2 of Methyltestosterone; Mesteron; Mesterone; Metandren; Methitest; Schering Brand of Methyltestosterone; Star Brand of Methyltestosterone; Testoviron; 17 Epimethyltestosterone; 17 alpha Methyltestosterone; 17 beta Hydroxy 17 methyl 4 androsten 3 one; 17alpha Methyl Testosterone; 17alpha Methyltestosterone; 17beta Hydroxy 17 methyl 4 androsten 3 one; 17beta Methyltestosterone; Android 10; Android 25; Android 5; Androst-4-en-3-one, 17-hydroxy-17-methyl-, (17beta)-

Relationship Network

Drug Context: Research Results

Experts

1.	Manigrasso, M R: 2 articles (10/2005 - 05/2005)
2.	Ferroni, P: 2 articles (10/2005 - 05/2005)
3.	Guagnano, M T: 2 articles (10/2005 - 05/2005)
4.	Murariu, G C: 1 article (10/2007)
5.	Coman, Adorata Elena: 1 article (10/2007)
6.	Petrovanu, Rodica: 1 article (10/2007)
7.	Petrovanu, Cynthia: 1 article (10/2007)
8.	Halpern, Alfredo: 1 article (02/2006)
9.	Costa, Ana Paula A C: 1 article (02/2006)
10.	Mancini, Marcio Corrêa: 1 article (02/2006)

Related Diseases

1.	Obesity 03/01/2001 - "INTRODUCTION: Studies about migration to industrialized countries have shown an increased prevalence of diabetes, obesity and dyslipidaemias, all of them related to android body fat distribution" 05/15/1999 - "The purpose of this study was to determine the familial risk of obesity and of an android profile of fat distribution in the general Canadian population" 10/01/1990 - "Aim of this study was the observation of some differences in eating habits and psychological status during a 24-hr period in relationship with the android or gynecoid type of obesity" 04/01/1988 - "Study of abdominal adipose tissue distribution using CAT in android type obesity]" 02/01/2008 - "Men are usually characterized by the android type of obesity, with accumulation of fat in the abdominal region, whereas women often display the gynoid type of obesity, with a greater proportion of their body fat in the gluteal-femoral region" Order ALL the reference details at left...
2.	Weight Loss (Weight Reduction) 11/01/1991 - "These results indicate that in obese android male and female subjects, adipose tissue distribution as measured by WHR, does not change in response to rapid weight loss." 10/23/2002 - "An additional study was conducted to determine the short-term effects of weight loss in 20 of the 44 women with android obesity" 10/23/2002 - "INTERVENTION: During a 12-week period, 20 women with android obesity followed a weight loss program to reduce caloric intake to about 1200 kcal/d" 07/01/1995 - "CONCLUSION: Postmenopausal women with an android and gynoid fat distribution respond with similar weight loss to treatment of overweight" 01/01/1992 - "Type of obesity (android or gynoid) as determined by waist to hip ratio had no significant impact on either weight loss, REW, reductions of waist and hip circumferences, or on waist to hip ratio changes" Order ALL the reference details at left...
3.	Erectile Dysfunction 10/01/1994 - "A study was designed to assess the effect of supplemental oral methyltestosterone in the treatment of impotence associated with low total serum androgen levels" 10/01/1994 - "Oral methyltestosterone is of limited effectiveness in men with hypogonadal impotence" 01/01/1970 - "The treatment of impotence with methyltestosterone thyroid (100 patients--double blind study)." 02/01/1964 - "TREATMENT OF IMPOTENCE WITH A METHYLTESTOSTERONE-THYROID COMPOUND." 09/01/1989 - "We describe a 64-year-old man who developed cholestatic jaundice after receiving 20 to 40 mg of methyltestosterone daily for 6 months for impotence but failed to mention it as part of his drug history" Order ALL the reference details at left...
4.	Adrenocortical Hyperfunction (Adrenal Gland Hyperfunction) 03/22/1952 - "Gynoid and android obesity; estrogenic hypercorticism.]" 06/01/2000 - "Several studies showed a significant association between an android fat distribution and an increased cortisol secretion, raising the still debated question of a causal relationship between the development of android obesity and hypercorticism" 09/01/1953 - "A case of hyperadrenocorticism with spontaneous improvement; effects of potassium acetate, corticotropin (ACTH), cortisone acetate, desoxycorticosterone acetate and methyltestosterone." Order ALL the reference details at left...
5.	Hyperlipidemias (Hyperlipidemia) 04/01/2000 - "CONCLUSIONS: Android obese patients with a fasting TG in the normal range and not different from the fasting TG of lean controls had an abnormal postprandial lipemia response, indicated by a significantly greater TG in the non-chylomicron subfraction than in controls" 04/01/2000 - "This study of 17 normotriglyceridemic, normoglucose-tolerant android obese subjects (body mass index, BMI = 34.3 +/- 3.1 kg/m2) and 33 normal-weight controls (BMI = 21.8 +/- 1.6 kg/m2) was done to examine their postprandial responses to an oral fat loading test containing retinol (890 calories, 85% fat) and to evaluate the possible association between clinical and biological features of obesity and/or insulin resistance and postprandial lipemia" 04/01/2003 - "Individuals exhibiting "the metabolic syndrome" have multiple coronary artery disease risk factors, including insulin resistance, hyperlipidemia, hypertension, and android obesity" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Insulin (Novolin)
2.	Glucose (Dextrose)
3.	Estrogens (Estrogen)
4.	Plasminogen Activator Inhibitor 1
5.	Testosterone (Sustanon)
6.	Hormones
7.	Cholesterol
8.	Methandriol
9.	Potassium Acetate
10.	Methylprednisolone

Related Therapies and Procedures

1.	Aftercare (After-Treatment)
2.	Hormone Replacement Therapy (Therapy, Hormone Replacement)
3.	Ovariectomy (Oophorectomy)
4.	Hypophysectomy
5.	Hair Removal (Depilation)